Medicare Enrolled
Dr. Paul Lin, MD
Hematology & Oncology · Wellington, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lin
Dr. Paul Lin is a hematology & oncology specialist in Wellington, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lin performed 602,784 Medicare services across 3,758 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lin received a total of $45,868 from 84 pharmaceutical and/or device companies across 1436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in FL
$45,868 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 95685 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗602,784
Medicare services
Top 0% in FL for hematology & oncology
3,758
Unique beneficiaries
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~31,725 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
267,660 | $0 | $1 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
165,000 | $1 | $2 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
51,060 | $0 | $1 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
43,350 | $0 | $3 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
35,230 | $6 | $13 |
| Denosumab injection (Prolia/Xgeva) | 10,620 | $17 | $28 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
6,726 | $36 | $70 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,840 | $6 | $25 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
3,371 | $8 | $19 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,983 | $8 | $10 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,534 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,935 | $99 | $228 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,804 | $11 | $31 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,520 | $1 | $23 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,432 | $70 | $156 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
512 | $51 | $150 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
457 | $1 | $10 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
447 | $23 | $66 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
365 | $12 | $35 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
280 | $16 | $45 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
263 | $105 | $294 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
222 | $129 | $348 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
178 | $58 | $105 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
158 | $1 | $3 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
148 | $26 | $80 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
145 | $29 | $82 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
113 | $1 | $12 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
79 | $75 | $213 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
68 | $10 | $29 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
60 | $100 | $150 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
58 | $23 | $64 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
56 | $18 | $48 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
51 | $134 | $306 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
23 | $1 | $8 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
23 | $2 | $6 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $107 | $292 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
36.1% high complexity
62.2% medium
1.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$45,868
Total received (2018-2024)
Avg $6,553/year across 7 years
Top 15% in FL for hematology & oncology
84
Companies
1,436
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,007 (61.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16,228 (35.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,634 (3.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,542
2023
$6,162
2022
$5,479
2021
$4,018
2020
$2,902
2019
$13,792
2018
$8,973
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$10,884
Dova Pharmaceuticals
$4,082
US Oncology Corporate, Inc.
$2,763
AstraZeneca Pharmaceuticals LP
$2,702
Genentech USA, Inc.
$2,216
PFIZER INC.
$2,015
Incyte Corporation
$1,746
Novartis Pharmaceuticals Corporation
$1,477
Amgen Inc.
$1,363
E.R. Squibb & Sons, L.L.C.
$1,306
Lilly USA, LLC
$1,193
Janssen Biotech, Inc.
$1,171
Seagen Inc.
$1,145
GENZYME CORPORATION
$1,134
Merck Sharp & Dohme LLC
$840
Eisai Inc.
$757
Merck Sharp & Dohme Corporation
$651
Takeda Pharmaceuticals U.S.A., Inc.
$581
Daiichi Sankyo Inc.
$454
Astellas Pharma US Inc
$425
Pharmacyclics LLC, An AbbVie Company
$400
ABBVIE INC.
$394
EISAI INC.
$378
Regeneron Healthcare Solutions, Inc.
$356
Seattle Genetics, Inc.
$333
Boehringer Ingelheim Pharmaceuticals, Inc.
$328
GlaxoSmithKline, LLC.
$295
PharmaEssentia USA Corporation
$271
Bayer HealthCare Pharmaceuticals Inc.
$253
AMAG Pharmaceuticals, Inc.
$238
JAZZ PHARMACEUTICALS INC.
$228
Exelixis Inc.
$213
SANOFI-AVENTIS U.S. LLC
$200
SEAGEN INC.
$189
ARRAY BIOPHARMA INC
$181
EMD Serono, Inc.
$147
Global Blood Therapeutics, Inc.
$122
Mirati Therapeutics, Inc.
$121
PUMA BIOTECHNOLOGY, INC.
$114
Rigel Pharmaceuticals, Inc.
$112
Gilead Sciences, Inc.
$109
Alexion Pharmaceuticals, Inc.
$108
AbbVie, Inc.
$107
Verastem, Inc.
$101
Foundation Medicine, Inc.
$101
AbbVie Inc.
$100
Pharmacosmos Therapeutics Inc.
$85
Puma Biotechnology, Inc.
$79
Otsuka America Pharmaceutical, Inc.
$76
Amneal Pharmaceuticals LLC
$68
Ipsen Biopharmaceuticals, Inc
$66
MEDIVATION FIELD SOLUTIONS LLC
$63
Kite Pharma, Inc.
$63
SOBI, INC
$52
Deciphera Pharmaceuticals Inc.
$51
Agios Pharmaceuticals, Inc.
$51
Pharmacyclics LLC, an AbbVie Company
$49
Azurity Pharmaceuticals, Inc.
$44
Mylan Institutional Inc.
$43
Bayer Healthcare Pharmaceuticals Inc.
$41
TAIHO ONCOLOGY, INC.
$41
BeiGene USA, Inc.
$41
Sandoz Inc.
$39
TG THERAPEUTICS, INC.
$37
Janssen Pharmaceuticals, Inc
$36
Sobi, Inc
$35
Stemline Therapeutics Inc.
$34
Adaptive Biotechnologies Corporation
$33
INSYS Therapeutics Inc
$31
Organon LLC
$31
ADC Therapeutics America, Inc.
$27
Dendreon Pharmaceuticals LLC
$26
SERVIER PHARMACEUTICALS LLC
$24
Kyowa Kirin, Inc.
$24
Abbott Laboratories
$24
Genmab U.S., Inc.
$23
Aveo Pharmaceuticals, Inc.
$23
NOVARTIS PHARMACEUTICALS CORPORATION
$20
Octapharma USA, Inc.
$17
Karyopharm Therapeutics Inc.
$17
TOLMAR Pharmaceuticals, Inc.
$15
Spectrum Pharmaceuticals Inc.
$13
Teva Pharmaceuticals USA, Inc.
$13
PORTOLA PHARMACEUTICALS, INC.
$11
Top 3 companies account for 38.7% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AUGTYRO · AVASTIN · Abraxane · Alecensa · Avastin · BAVENCIO · BENDEKA · BESREMI · BEVYXXA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · EnSite X · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fulphila · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SYNDROS · Stivarga · TAFINLAR · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · UKONIQ · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZARXIO · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (61%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
43
Per 100K population
2.9
County median income
$81,115
Nearest hospital
WELLINGTON REGIONAL MEDICAL CENTER
5.8 mi
5.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lin is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), with low-engagement industry engagement in the top 15% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lin experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Lin performed 267,660 filgrastim injection (nivestym) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lin receive payments from pharmaceutical companies?
Yes. Dr. Lin received a total of $45,868 from 84 companies across 1,436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lin's costs compare to other hematology & oncology specialists in Wellington?
Dr. Lin's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Wellington
Browse hematology & oncology specialists in Wellington ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Dova Pharmaceuticals Payments to Doctors
See all physicians who received payments from Dova Pharmaceuticals.
By company
US Oncology Corporate, Inc. Payments to Doctors
See all physicians who received payments from US Oncology Corporate, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology